Colorectal Cancer (CRC) Completed Phase 3 Trials for Capecitabine (DB01101)

Back to Colorectal Cancer (CRC)

Also known as: Malignant Neoplasm of Colorectum / CRC, Colorectal Cancer / Colorectal Cancer / Cancer, Colorectal / CRC (Colorectal Cancer) / Colorectal, Cancer / Colo-rectal Cancer / Colorectal Cancers / A. Colorectal Cancer / Cancer Colorectal / Gastrointestinal Cancers - Colorectal / CRC / CRCS / Malignant colorectal neoplasm / Malignant neoplasm of cecum and/or colon and/or rectum / Malignant neoplasm of caecum and/or colon and/or rectum / Malignant neoplasm of cecum and/or colon and/or rectum (disorder) / Malignant neoplasm of large intestine / Malignant tumor of large intestine / Malignant tumour of large intestine / Malignant neoplasm of large intestine (disorder) / Malignant neoplasm of colon, unspecified / Malignant large intestinal neoplasm NOS / Cancer of large intestine / Malignant neoplasm of large intestine, NOS / Cancer of large bowel / CA - Cancer of large bowel / Colorectal neoplasms malignant / Malignant neoplasm of colon and/or rectum (disorder) / Large intestine carcinoma / Colorectal carcinoma / Colorectal cancer NOS

Indication	Status	Phase
DBCOND0031867 (Colorectal Cancer (CRC))	Completed	3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00312000	Sequential Versus Combination Chemotherapy in Advanced Colorectal Carcinoma	Treatment	Capecitabine (DB01101) Irinotecan (DB00762)
NCT02251977	Effect of GM1 in Prevention of Oxaliplatin Induced Neurotoxicity in Stage II/III Colorectal Cancer	Prevention	Capecitabine (DB01101) Fluorouracil (DB00544) Ganglioside GM1 (DB16948) Leucovorin (DB00650)
NCT00227747	Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer	Treatment	Capecitabine (DB01101) Oxaliplatin (DB00526)
NCT00905047	Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer	Treatment	Capecitabine (DB01101) Leucovorin (DB00650) Propylthiouracil (DB00550) Tegafur (DB09256)
NCT00623805	A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer	Treatment	Bevacizumab (DB00112) Capecitabine (DB01101) Oxaliplatin (DB00526)
NCT01229813	Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer.	Treatment	Bevacizumab (DB00112) Capecitabine (DB01101) Erlotinib (DB00530)
NCT00070213	Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer	Treatment	Capecitabine (DB01101) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00202774	Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer	Treatment	Capecitabine (DB01101) Fluorouracil (DB00544) Oxaliplatin (DB00526)
NCT01718873	Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer	Treatment	Bevacizumab (DB00112) Capecitabine (DB01101) Fluorouracil (DB00544) Leucovorin (DB00650) Levoleucovorin (DB11596) Oxaliplatin (DB00526)
NCT00069095	A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer	Treatment	Bevacizumab (DB00112) Capecitabine (DB01101) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00766155	Chemotherapy and Radiation Therapy Before Surgery Followed by Capecitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced Rectal Cancer	Treatment	Capecitabine (DB01101) Oxaliplatin (DB00526)
NCT00749450	Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer	Treatment	Capecitabine (DB01101) Fluorouracil (DB00544) Oxaliplatin (DB00526)
NCT00069108	A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer	Treatment	Capecitabine (DB01101) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00069121	A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer	Treatment	Capecitabine (DB01101) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00009737	A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer	Treatment	Capecitabine (DB01101) Fluorouracil (DB00544) Leucovorin (DB00650)
NCT01918852	S-1 Versus Capecitabine in the First Line Treatment of MCC Patients.	Treatment	Bevacizumab (DB00112) Capecitabine (DB01101) Gimeracil (DB09257)
NCT00427713	Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer	Treatment	Capecitabine (DB01101) Oxaliplatin (DB00526)
NCT01097018	Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer	Treatment	Capecitabine (DB01101) Perifosine (DB06641)
NCT00112918	Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer	Treatment	Bevacizumab (DB00112) Capecitabine (DB01101) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00484939	A Study of Bevacizumab (Avastin) in Combination With Capecitabine (Xeloda) in Elderly Patients With Metastatic Colorectal Cancer	Treatment	Bevacizumab (DB00112) Capecitabine (DB01101)
NCT00062426	Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer	Treatment	Bevacizumab (DB00112) Capecitabine (DB01101) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00212589	Patients Preference for Oral or i.v. Therapy	Treatment	Capecitabine (DB01101) Fluorouracil (DB00544) Leucovorin (DB00650)
NCT00064181	Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer	Treatment	Capecitabine (DB01101) Celecoxib (DB00482) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650)
NCT00469443	Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC	Treatment	Bevacizumab (DB00112) Capecitabine (DB01101) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650)
NCT00677443	Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer	Treatment	Capecitabine (DB01101) Oxaliplatin (DB00526)